Literature DB >> 35314906

The Physical Stability of Felodipine and Its Recrystallization from an Amorphous Solid Dispersion Studied by NMR Relaxometry.

A Pajzderska1, J Mielcarek2, J Wąsicki3,4.   

Abstract

The 1H nuclear magnetic resonance (NMR) relaxometry method was applied to investigate the physical stability of an active pharmaceutical ingredient (API) and, for the first time, its recrystallization process in an amorphous solid dispersion system (ASD). The ASD of felodipine and polyvinylpyrrolidone (PVP) was prepared using the solvent evaporation method in a mass ratio of 50:50. In the first stage of the study (250 days), the sample was stored at 0% relative humidity (RH). The recovery of magnetization was described by one-exponential function. In the second stage (300 days in 75% relative humidity), the recrystallization process of felodipine was studied, showing in the sample three components of equilibrium magnetization related to (i) crystalline felodipine, (ii) water, and (iii) felodipine and PVP remaining in the ASD. The study shows that the 1H NMR relaxometry method is a very useful tool for analysing the composition of a three-phase system mixed at the molecular level and for the investigation of recrystallization process of API in amorphous solid dispersion system.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  PVP; amorphous solid dispersion; felodipine; physical stability; recrystallization; relaxometry; time-domain NMR

Mesh:

Substances:

Year:  2022        PMID: 35314906     DOI: 10.1208/s12249-022-02234-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  41 in total

Review 1.  Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.

Authors:  R Löbenberg; G L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

2.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

Review 3.  An analysis of the attrition of drug candidates from four major pharmaceutical companies.

Authors:  Michael J Waring; John Arrowsmith; Andrew R Leach; Paul D Leeson; Sam Mandrell; Robert M Owen; Garry Pairaudeau; William D Pennie; Stephen D Pickett; Jibo Wang; Owen Wallace; Alex Weir
Journal:  Nat Rev Drug Discov       Date:  2015-06-19       Impact factor: 84.694

4.  Crystals and Crystallization in Drug Delivery Design.

Authors:  Lynne S Taylor; Doris E Braun; Jonathan W Steed
Journal:  Mol Pharm       Date:  2021-02-17       Impact factor: 4.939

Review 5.  Effects of the Preparation Process on the Properties of Amorphous Solid Dispersions.

Authors:  Siyuan Huang; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2017-09-18       Impact factor: 3.246

6.  Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.

Authors:  Alfred C F Rumondor; Patrick J Marsac; Lindsay A Stanford; Lynne S Taylor
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

7.  Stable amorphous binary systems of glipizide and atorvastatin powders with enhanced dissolution profiles: formulation and characterization.

Authors:  Sachin Kumar Singh; Monica Gulati; Rakesh Narang
Journal:  Pharm Dev Technol       Date:  2015-12-27       Impact factor: 3.133

8.  Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.

Authors:  Hajime Konno; Lynne S Taylor
Journal:  Pharm Res       Date:  2007-05-23       Impact factor: 4.200

Review 9.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

Review 10.  Mechanisms of increased bioavailability through amorphous solid dispersions: a review.

Authors:  Andreas Schittny; Jörg Huwyler; Maxim Puchkov
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.